Purchase Order 36C25022P0874
- Not listed
- Cepheid has been awarded a firm fixed-price delivery order valued at $40,704.72 by the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9). The contract, with an ultimate completion date of May 31, 2025, is for molecular diagnostic solutions to be delivered and performed in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of advanced diagnostic systems and testing solutions to the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, received a $79,343.96 firm fixed-price purchase order from Veterans Integrated Service Network (VISN) 10 for Cepheid GeneXpert supplies, with a completion date of March 31, 2026. The award, announced on January 1, 2026, represents a standalone purchase order with no set-aside designation and reflects the Department of Veterans Affairs' continued reliance on Cepheid as a primary supplier of diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents, was awarded a firm fixed-price purchase order valued at $918,235.12 by Veterans Integrated Service Network (VISN) 17, a component of the Department of Veterans Affairs, with an award date of October 1, 2021, and ultimate completion date of September 30, 2026. This contract, designated as "AMA CEPHEID SUPPLIES-MOD - OY4 - FUNDED," contains no set-aside designation and represents a...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a definitive firm fixed-price contract valued at $892,066.93 by the Department of Veterans Affairs' Veterans Integrated Service Network 5 on March 23, 2024, with an ultimate completion date of March 22, 2029. The contract, which carries no set-aside designation, is to be performed in Baltimore, Maryland. This award represents a continuation of Cepheid's substantial role as a primary...
- Cepheid Inc. has been awarded a delivery order valued at $333,567.56 by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21), with a firm fixed-price structure and ultimate completion date of March 15, 2026. This delivery order represents a continuation of the agency's procurement of molecular diagnostic solutions from Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and reagents. The award carries no set-aside...
- Cepheid Inc. was awarded a firm fixed-price purchase order valued at $570,182.92 by Veterans Integrated Service Network 6 (VISN 6), a civilian component of the Department of Veterans Affairs, for Cepheid service contract and service agreement work. The contract was awarded on February 10, 2023, with an ultimate completion date of February 9, 2027, and the place of performance is located in Fayetteville, North Carolina. This award carries no set-aside designation and represents a continuation...
- Cepheid Inc. was awarded a $306,000 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) on October 1, 2025, for the supply of Cepheid testing kits. The contract carries an ultimate completion date of March 31, 2026, with no set-aside designation. As a molecular diagnostics manufacturer headquartered in Sunnyvale, California, Cepheid supplies the federal healthcare system with advanced diagnostic solutions, particularly its...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order contract valued at $201,413.10 by the Veterans Integrated Service Network (VISN) 23, a component of the Department of Veterans Affairs. The contract, issued on October 1, 2024, with an ultimate completion date of September 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation for the provision of laboratory supplies. The...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $33,767.36 by Veterans Integrated Service Network (VISN) 17 on July 3, 2026, for GeneXpert diagnostic services supporting the El Paso facility. The contract has no set-aside designation and carries a completion date of June 30, 2027. This delivery order is issued under Cepheid's broader Indefinite Delivery Contract with VISN 17, valued at $6.74 million...
- Cepheid has been awarded an annual maintenance agreement purchase order valued at $148,000 by the Department of Veterans Affairs' Veterans Integrated Service Network 6 (VISN 6). This firm fixed-price contract, with an ultimate completion date of October 31, 2026, supports Cepheid's molecular diagnostic solutions at the VA facility in Richmond, Virginia. The award was issued on November 1, 2021, following a special notice solicitation posted on October 7, 2021, with no set-aside designation...
Cepheid Inc. was awarded a $92,500 firm fixed-price purchase order by the Department of Veterans Affairs, Veterans Integrated Service Network 10 (VISN 10) on May 17, 2022, for GeneXpert maintenance services. The contract, with an ultimate completion date of May 16, 2027, will be performed in Saginaw, Michigan. This award carries no set-aside designation and represents routine maintenance support for Cepheid's diagnostic platform, which is widely deployed across VA healthcare facilities for molecular diagnostic testing of infectious diseases including COVID-19, influenza, tuberculosis, and other conditions critical to veteran healthcare delivery. This purchase order is part of Cepheid's broader portfolio of federal contracts with the VA, where the company serves as a primary supplier of molecular diagnostic solutions across multiple Veterans Integrated Service Networks. Cepheid holds two significant indefinite delivery contracts with the VA—a $6.7 million single-award contract with VISN 17 and a substantially larger $32.8 million single-award contract with VISN 6, both extending through 2029-2030—establishing the company as the VA's core molecular diagnostics vendor. The company's expertise in providing diagnostic equipment, reagents, test kits, and maintenance services positions it as a critical partner in supporting the VA's clinical laboratory operations and infectious disease testing capabilities across its nationwide network of medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $18.5k | 2/3/26 | |
| P00003 | Exercise an Option | $18.5k | 3/13/25 | |
| P00002 | Exercise an Option | $18.5k | 4/15/24 | |
| P00001 | Exercise an Option | $18.5k | 4/17/23 | |
| Not listed | Not listed | $18.5k | 4/25/22 |